Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bhavesh Ashar currently holds 56,330 shares of SpringWorks Therapeutics, Inc. (SWTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bhavesh Ashar has been a net seller of SWTX stock. They have purchased $0 and sold $381.4K worth of shares.
Bhavesh Ashar's most recent insider trade was on Jul 1, 2025, when they sold 62,053 shares at $0.00 per share.
Bhavesh Ashar serves as Executive at SpringWorks Therapeutics, Inc. (SWTX). They have executed 17 insider transactions totaling $381.4K over their tenure at the company.
Bhavesh Ashar holds the position of Executive at SpringWorks Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Bhavesh Ashar has shown a selling trading pattern, with $0 in total purchases and $381.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bhavesh Ashar was on Feb 5, 2024, when they sold $238.4K worth of SWTX shares. This transaction involved 4,834 shares at $49.32 per share.
Bhavesh Ashar currently owns 56,330 shares of SpringWorks Therapeutics, Inc. (SWTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bhavesh Ashar's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bhavesh Ashar has 17 Form 4 filings on record as an insider at SpringWorks Therapeutics, Inc..
Set alerts for Bhavesh Ashar and 40,000+ other insiders.